FDAnews
www.fdanews.com/articles/206491-genetic-analysiss-ga-map-dysbiosis-test-for-microbiome-gains-ce-mark

Genetic Analysis’s GA-map Dysbiosis Test for Microbiome Gains CE Mark

February 8, 2022

Oslo, Norway-based Genetic Analysis has received a CE mark for its GA-map microbiome test for the Luminex MAGPIX instrument system.

The test generates a profile of a person’s gut flora and connects the profile to the patient’s health conditions, including irritable bowel syndrome, inflammatory bowel disease, type 2 diabetes, gut disorder (gastrointestinal problems), lifestyle diseases and leaky-gut syndrome.

The test previously earned a CE mark for use with the Luminex LX200 system. The GA-map’s  availability for the lower-cost Luminex MAGPIX system will allow more users to install the test platform, the company said.

View today's stories